← Leaderboards
Patrick Lee Green
Ohio State University
$10,720,230
Attributed
$10,720,230
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$33,222,473 · 17
By mechanism
P01$29,287,577 · 6
R01$2,108,731 · 2
R21$1,677,730 · 4
R03$120,960 · 1
R13$27,475 · 4
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Michael D Lairmore$5,085,750
- Louis M Mansky$15,115,622
- Stefan Niewiesk$7,548,978
- Kristine E Yoder$6,387,948
- Bevin Zimmerman$257,118
Others in their field
Top investigators on “Retroviridae”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- John M Coffin · Miriam Hospital$18,400,250
- Ellis L Reinherz · Dana-Farber Cancer Institute$16,769,846
- Tatyana V. Golovkina · Jackson Laboratory$16,114,627
- John M. Sedivy · Brown University$12,925,113
- Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences$11,669,600
Research focus
RetroviridaeViralHuman T-Lymphotropic Virus 1PathogenesisInfectionT-LymphocyteCancer ModelCollaborationsCellsProteinsAdult T-Cell Leukemia/LymphomaMalignant NeoplasmsProgramsIn VitroAnimal ModelMediatingTaxesFundingMessenger RnaCellular BiologyGene ExpressionVirusLeukemia/LymphomaHuman T-Lymphotropic Virus 2
Grant awards (69)
Retrovirus Models of Cancer$1,719,078
P01 · FY2024 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$285,081
P01 · FY2024 · CA · contact PI
Core A: Administration and Biostatistics$181,854
P01 · FY2024 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$72,960
P01 · FY2024 · CA · contact PI
Retrovirus Models of Cancer$72,960
P01 · FY2024 · CA · contact PI
33rd International Workshop on Retroviral Pathogenesis$10,000
R13 · FY2024 · CA · contact PI
Retrovirus Models of Cancer$1,809,557
P01 · FY2023 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$300,132
P01 · FY2023 · CA · contact PI
Core A: Administration and Biostatistics$194,798
P01 · FY2023 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$76,801
P01 · FY2023 · CA · contact PI
Retrovirus models of cancer P01CA100730 Diversity Supplement$76,801
P01 · FY2023 · CA · contact PI
Retrovirus Models of Cancer$1,773,364
P01 · FY2022 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$294,128
P01 · FY2022 · CA · contact PI
Core A: Administration and Biostatistics$190,902
P01 · FY2022 · CA · contact PI
32nd International Workshop on Retroviral Pathogenesis$4,475
R13 · FY2022 · CA · contact PI
Retrovirus Models of Cancer$1,809,557
P01 · FY2021 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$368,072
P01 · FY2021 · CA · contact PI
Core A: Administration and Biostatistics$207,040
P01 · FY2021 · CA · contact PI
Retrovirus Models of Cancer$1,837,557
P01 · FY2020 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$368,072
P01 · FY2020 · CA · contact PI
Genome editing to prevent HTLV-1 disease$234,000
R21 · FY2020 · AI · contact PI
Core A: Administration and Biostatistics$207,040
P01 · FY2020 · CA · contact PI
Genome editing to prevent HTLV-1 disease$195,000
R21 · FY2019 · AI · contact PI
31st International Workshop on Retroviral Pathogenesis$5,000
R13 · FY2019 · CA · contact PI
Retrovirus Models of Cancer$1,805,984
P01 · FY2018 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$351,024
P01 · FY2018 · CA · contact PI
Core A: Administration and Biostatistics$202,493
P01 · FY2018 · CA · contact PI
Retrovirus Models of Cancer$109,684
P01 · FY2018 · CA · contact PI
Core A: Administration and Biostatistics$18,282
P01 · FY2018 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$18,280
P01 · FY2018 · CA · contact PI
30th International Workshop on Retroviral Pathogenesis$8,000
R13 · FY2018 · CA · contact PI
Retrovirus Models of Cancer$1,799,120
P01 · FY2017 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$349,683
P01 · FY2017 · CA · contact PI
Core A: Administration and Biostatistics$201,738
P01 · FY2017 · CA · contact PI
Retrovirus Models of Cancer$109,098
P01 · FY2017 · CA · contact PI
Retrovirus Models of Cancer$50,560
P01 · FY2017 · CA · contact PI
Retrovirus Models of Cancer$1,792,351
P01 · FY2016 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$349,419
P01 · FY2016 · CA · contact PI
Role of PRMT5 in HTLV-1 transformation and disease$231,000
R21 · FY2016 · AI · contact PI
Core A: Administration and Biostatistics$198,909
P01 · FY2016 · CA · contact PI
Retrovirus Models of Cancer$1,785,690
P01 · FY2015 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$347,058
P01 · FY2015 · CA · contact PI
Core A: Administration and Biostatistics$200,261
P01 · FY2015 · CA · contact PI
Role of PRMT5 in HTLV-1 transformation and disease$192,500
R21 · FY2015 · AI · contact PI
Retrovirus Models of Cancer$1,790,956
P01 · FY2014 · CA · contact PI
Project 1: Role of HTLV-1 Hbz in Transformation and Disease$333,790
P01 · FY2014 · CA · contact PI
Core A: Administration and Biostatistics$187,558
P01 · FY2014 · CA · contact PI
Role of viral APH-2 in HTLV-2 replication and persistence$228,750
R21 · FY2013 · AI · contact PI
Retrovirus Models of Lymphocyte Transformation and Disease$2,075,370
P01 · FY2012 · CA · contact PI
Mechanisms of Post-Transcriptional Control by HTLV p28$265,729
P01 · FY2012 · CA · contact PI
Role of viral APH-2 in HTLV-2 replication and persistence$190,625
R21 · FY2012 · AI · contact PI
Retrovirus Models of Lymphocyte Transformation and Disease$2,084,556
P01 · FY2011 · CA · contact PI
Mechanisms of Post-Transcriptional Control by HTLV p28$267,279
P01 · FY2011 · CA · contact PI
Mechanisms of Post-Transcriptional Control by HTLV p28$277,320
P01 · FY2010 · CA · contact PI
Mechanisms of Post-Transcriptional Control by HTLV p28$272,658
P01 · FY2009 · CA · contact PI
Molecular determinants of HTLV cellular transformation$271,103
R01 · FY2009 · CA · contact PI
Molecular determinants of HTLV cellular transformation$271,103
R01 · FY2008 · CA · contact PI
Mechanisms of Post-Transcriptional Control by HTLV p28$196,973
P01 · FY2008 · CA · contact PI
Molecular determinants of HTLV cellular transformation$271,103
R01 · FY2007 · CA · contact PI
Molecular determinants of HTLV cellular transformation$248,177
R01 · FY2006 · CA · contact PI
Role of viral HBZ in HTLV-1 replication and pathogenesis$218,980
R21 · FY2006 · AI · contact PI
Molecular determinants of HTLV cellular transformation$275,400
R01 · FY2005 · CA
Role of viral HBZ in HTLV-1 replication and pathogenesis$186,875
R21 · FY2005 · AI
Structure-Function Analyses of HIV Rev and HTLV Rex$40,320
R03 · FY2004 · TW
Structure-Function Analyses of HIV Rev and HTLV Rex$40,320
R03 · FY2003 · TW
Role of HTLV Rex in Viral Replication &Transformation$284,726
R01 · FY2002 · CA
Structure-Function Analyses of HIV Rev and HTLV Rex$40,320
R03 · FY2002 · TW
ROLE OF HTLV TAX IN THE TRANSFORMATION OF HUMAN T CELLS$246,063
R01 · FY2001 · CA
ROLE OF HTLV TAX IN THE TRANSFORMATION OF HUMAN T CELLS$241,056
R01 · FY2000 · CA